|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01K 67/027 | |
| C12N 15/90 | |||
| C07K 14/705 |
| (11) | Number of the document | 2922394 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14781783.7 |
| Date of filing the European patent application | 2014-09-23 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/056910 |
| Date | 2014-09-23 |
| (87) | Number | WO 2015/042557 |
| Date | 2015-03-26 |
| (30) | Number | Date | Country code |
| 201361881261 P | 2013-09-23 | US |
| (72) |
MURPHY, Andrew J., US
THURSTON, O. Gavin, US
VARGHESE, Bindu, US
GURER, Cagan, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE |
| NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE |